These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37896791)

  • 1. Trend of HPV Molecular Epidemiology in the Post-Vaccine Era: A 10-Year Study.
    Lin Y; Lin WY; Lin TW; Tseng YJ; Wang YC; Yu JR; Chung CR; Wang HY
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    Sarmiento-Medina MI; de Amaya MP; Villamizar-Gómez L; González-Coba AC; Guzmán-Barajas L
    PLoS One; 2024; 19(2):e0297579. PubMed ID: 38315664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
    Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
    Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
    Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
    BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
    Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
    BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
    Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
    Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions.
    Li J; Gao JJ; Li N; Wang YW
    Arch Virol; 2021 Mar; 166(3):853-862. PubMed ID: 33486629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
    Ruan Y; Li H; Liu M; Cao G; Xu X; Han L; Li F
    Cancer Epidemiol; 2023 Jun; 84():102372. PubMed ID: 37119603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women.
    Hernández-Silva CD; Ramírez de Arellano A; Pereira-Suárez AL; Ramírez-López IG
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women.
    Abate A; Munshea A; Nibret E; Alemayehu DH; Alemu A; Abdissa A; Mihret A; Abebe M; Mulu A
    Sci Rep; 2024 Apr; 14(1):7976. PubMed ID: 38575600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
    BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review.
    Ouedraogo RA; Kande A; Nadembega WMC; Ouermi D; Zohoncon TM; Djigma FW; Ouedraogo CMR; Lompo OM; Simpore J
    J Egypt Natl Canc Inst; 2023 Dec; 35(1):39. PubMed ID: 38060078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
    Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
    J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer.
    Nagaraja M; Narendra H; Venkataramana B; Kalawat U
    Indian J Med Microbiol; 2023; 43():73-78. PubMed ID: 36241529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.
    Pärna K; Nygård M; Tisler A; Toompere K; Naaber P; Ratnik K; Ķīvīte Urtāne A; Zodzika J; Stankūnas M; Baltzer N; Uusküla A
    BMJ Open; 2023 Jun; 13(6):e069558. PubMed ID: 37263686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
    Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
    BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
    Wang T; Luan L; Deng J; Liu N; Wu Q; Gong T; Zhu J; Zhang Z; Zhang J
    Hum Vaccin Immunother; 2023 Aug; 19(2):2241309. PubMed ID: 37519009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.